Recurrent cervical cancer - Therapeutic options;Nawrotowy rak szyjki macicy - Opcje terapeutyczne

Ginekologia Polska

Volumn 83, Issue 7, 2012, Pages 527-531

  Ziłciak Siwińska, Agnieszka ^a   Jońska Gmyrek, Joanna ^a   Socha, Joanna ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Brachytherapy; Cervical cancer; Egzenteration; Radiotherapy; Reirradiation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGE; AGED; BRACHYTHERAPY; CANCER STAGING; FEMALE; HUMAN; HYSTERECTOMY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE; UTERINE CERVIX TUMOR; WOMEN'S HEALTH;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; WOMEN'S HEALTH;

MLCS; MLOWN;

EID: 84865829877     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wojciechowska U, Didkowska J, Zatoński W. Cancer in Poland in 2008. Krajowy Rejestr Nowotworów. 2010, 36.
2. Mabuchi S, Isohashi F, Yoshioka Y, [et al.]. Prognostic factors for survival in patients with recurrent cervical cancer previously treated with radiotherapy. Int J Gynecol Cancer. 2010, 20, 834-840.
3. Haasbeek C, Uitterhoeve A, van der Velden J, [et al.]. Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery. Radiother Oncol. 2008, 89, 197-204.
4. Chiva L, Lapuente F, Gonzalez-Cortijo L, [et al.]. Surgical treatment of recurrent cervical cancer: state of the art and new achievements. Gynecol Oncol. 2008, 110, 60-66.
5. Magrina J. Types of pelvic exenterations: a reappraisal. Gynecol Oncol. 1990, 37, 363-366.
6. Jurando M, Alcazar J, Martinez-Monge R. Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? A twenty-year experience. Gynecol Oncol. 2010, 116, 38-43.
7. Spahn M, Weiss C, Bader P, [et al.]. The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival. Urol Int. 2010, 85, 16-22.
8. Torres-Lobaton A, Lara-Gutierrez C, Torres-Rojo A, [et al.]. Pelvic exenterations for cervical cancer (prognosis factors). Ginecol Obstet Mex. 2010, 78, 598-604.
9. Leitao M, Chi D. Recurrent cervical cancer. Curr Treat Options Oncol. 2002, 3, 105-111.
10. Gemignani M, Alektiar K, Leitao M, [et al.]. Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers. Int J Radiat Oncol Biol Phys. 2001, 50, 687-694.
11. Hicks M, Piver M, Mas E, [et al.]. Intraoperative orthovoltage radiation therapy in the treatment of recurrent gynecologic malignancies. Am J Clin Oncol. 1993, 16, 497-500.
12. Cella D, Huang H, Monk B, [et al.]. Health-related quality of life outcomes associated with four cisplatin - based double chemotherapy regiments for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group Study. Gynecol Oncol. 2010, 119, 531-537.
13. Moore D, Tian C, Monk B, [et al.]. Prognostic factors for response to cisplatin - based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol. 2010, 116, 44-49.
14. Franckena M, De Witt R, Ansink A, [et al.]. Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area. Int J Hyperthermia. 2007, 23, 443-450.
15. Badakh D, Grover A. Reirradiation with high-dose-rate remote afterloading brachytherapy implant in patients with locally recurrent or residual cervical carcinoma. J Cancer Res Ther. 2009, 5, 24-30.
16. Weitmann H, Knocke T, Waldhausl C, Pöter R. Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma. Strahlenther Oncol. 2006, 182, 86-95.
17. Randall M, Evans L, Greven K, [et al.]. Interstitial reirradiation for recurrent gynecologic malignancies: results and analysis of prognostic factors. Gynecol Oncol. 1993, 48, 23-31.
18. Emami B, Scott Ch, Perez C, [et al.]. Phase III Study of interstitial thermo-radiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1996, 34, 1097-1104.